<p>PetMed Express（納斯達克股票代碼：PETS - 獲取免費報告）於週五發佈了其財報。該公司報告本季度每股收益為（$0.41），低於市場共識預期的$0.04，差距為（$0.45）。PetMed Express 的股本回報率為負 6.76%，淨利潤率為負 2.76%。</p>
<p>獲取 <strong>PetMed Express</strong> 的提醒：</p>
<h2>PetMed Express 價格表現</h2>
<ul>
<li>Petco Health &amp; Wellness 是否因每股收益超預期而擺脱困境？</li>
</ul>
<p>週五交易時段，PETS 股票下跌$0.05，報$3.60。該公司的交易量為 477,306 股，而其平均交易量為 792,454 股。PetMed Express 的 12 個月低點為$1.57，12 個月高點為$5.58。該公司的 50 日簡單移動平均為$2.34，200 日簡單移動平均為$2.89。公司的市值為 7693 萬美元，市盈率為-12.00，貝塔係數為 0.75。</p>
<h2>華爾街分析師預測增長</h2>
<p>PETS 已成為幾份分析師報告的主題。華爾街 Zen 在 10 月 18 日的研究報告中將 PetMed Express 的評級從 “持有” 下調至 “賣出”。Zacks Research 在 9 月 29 日的研究報告中將 PetMed Express 的評級從 “強烈賣出” 上調至 “持有”。最後，Weiss Ratings 在 10 月 8 日的研究報告中重申了對 PetMed Express 的 “賣出（d）” 評級。一位投資分析師對該股票給予了 “持有” 評級，另外兩位分析師則給予了 “賣出” 評級。根據 MarketBeat.com 的數據，PetMed Express 的共識評級為 “賣出”，共識目標價為$3.20。</p>
<ul>
<li>這裏有一隻不在困境中的寵物股票</li>
</ul>
<p><strong>查看我們對 PetMed Express 的最新股票分析</strong></p>
<h2>PetMed Express 的機構交易</h2>
<p>幾家對沖基金最近增加或減少了對該股票的持倉。Dimensional Fund Advisors LP 在第三季度將其在 PetMed Express 的持倉提高了 5.4%。Dimensional Fund Advisors LP 目前擁有 481,517 股該公司股票，價值$1,209,000，此前在上個季度購買了 24,624 股。Man Group plc 在第三季度將其在 PetMed Express 的持倉提高了 7.1%。Man Group plc 目前擁有 151,039 股該公司股票，價值$379,000，此前在上個季度增加了 9,989 股。Bridgeway Capital Management LLC 在第三季度將其在 PetMed Express 的持倉增加了 164.3%。Bridgeway Capital Management LLC 目前擁有 107,816 股該公司股票，價值$271,000，此前在上個季度增加了 67,016 股。CIBC Bancorp USA Inc.在第三季度購買了 PetMed Express 的新頭寸，價值$153,000。最後，Goldman Sachs Group Inc.在第一季度將其在 PetMed Express 的持倉提高了 59.3%。Goldman Sachs Group Inc.目前擁有 33,209 股該公司股票，價值$139,000，此前在上個季度購買了 12,360 股。機構投資者持有該公司 73.33% 的股票。</p>
<h2>PetMed Express 公司簡介</h2>
<p>（獲取免費報告）</p>
<ul>
<li>這 5 只寵物護理股票中的一隻可能成為下一個空頭擠壓</li>
</ul>
<p>PetMed Express, Inc.以 1-800-PetMeds 品牌名義運營，作為一家在線和目錄式寵物藥房及零售供應商。該公司直接向消費者分發處方和非處方藥物、營養補充劑、跳蚤和蜱蟲控制產品以及一系列寵物健康用品。通過其位於佛羅里達州德爾雷海灘的持牌獸醫藥房，PetMed Express 為狗、貓和其他伴侶動物處理訂單，提供品牌和仿製產品以及自有品牌配方。</p>
<p>PetMed Express 於 1996 年由 Marc Puleo 創立，基於為尋求可靠獸醫藥物的寵物主人提供便利和節省成本的理念建立了其業務。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過 PetMed Express</li>
<li>公用事業股票解析 – 如何以及為何投資公用事業</li>
<li>Nike 在收益上超預期，但在中國面臨困難並遭遇關税</li>
<li>便士股票適合你的投資組合嗎？</li>
<li>人工智能熱潮是泡沫嗎？這兩隻分紅股票説不是</li>
<li>投資者如何識別併成功交易缺口下跌股票</li>
<li>2026 年四隻高潛力 ETF：小型股、太空股票等</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEVUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEVUUw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資$1,000 在 PetMed Express 嗎？</h2>
<p>在考慮 PetMed Express 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 PetMed Express 並不在名單上。</p>
<p>雖然 PetMed Express 目前在分析師中獲得 “賣出” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

PETS

<p>PetMed Express 報告的季度每股收益為（$0.41），低於分析師預期$0.45。該公司的淨利潤率為負 2.76%，股本回報率為負 6.76%。股價下跌至$3.60，市值為$7693 萬美元。分析師一致給予 “賣出” 評級，目標價為$3.20。機構投資者持有 73.33% 的股份</p>

<p>PetMed Express (NASDAQ:PETS - Get Free Report) posted its earnings results on Friday. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.45), reports. PetMed Express had a negative return on equity of 6.76% and a negative net margin of 2.76%.</p>
<div class="lb-trans"><p>PetMed Express（納斯達克股票代碼：PETS - 獲取免費報告）於週五發佈了其財報。該公司報告本季度每股收益為（$0.41），低於市場共識預期的$0.04，差距為（$0.45）。PetMed Express 的股本回報率為負 6.76%，淨利潤率為負 2.76%。</p>
</div><p>Get <strong>PetMed Express</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>PetMed Express</strong> 的提醒：</p>
</div><h2>PetMed Express Price Performance</h2>
<div class="lb-trans"><h2>PetMed Express 價格表現</h2>
</div><ul>
<li>Is Petco Health &amp; Wellness Out of the Doghouse on an EPS beat?</li>
</ul>
<div class="lb-trans"><ul>
<li>Petco Health &amp; Wellness 是否因每股收益超預期而擺脱困境？</li>
</ul>
</div><p>Shares of PETS stock traded down $0.05 during trading hours on Friday, reaching $3.60. The company had a trading volume of 477,306 shares, compared to its average volume of 792,454. PetMed Express has a 12 month low of $1.57 and a 12 month high of $5.58. The business has a fifty day simple moving average of $2.34 and a 200-day simple moving average of $2.89. The company has a market cap of $76.93 million, a price-to-earnings ratio of -12.00 and a beta of 0.75.</p>
<div class="lb-trans"><p>週五交易時段，PETS 股票下跌$0.05，報$3.60。該公司的交易量為 477,306 股，而其平均交易量為 792,454 股。PetMed Express 的 12 個月低點為$1.57，12 個月高點為$5.58。該公司的 50 日簡單移動平均為$2.34，200 日簡單移動平均為$2.89。公司的市值為 7693 萬美元，市盈率為-12.00，貝塔係數為 0.75。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>PETS has been the topic of several analyst reports. Wall Street Zen lowered PetMed Express from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research report on Saturday, October 18th. Zacks Research upgraded shares of PetMed Express from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, September 29th. Finally, Weiss Ratings restated a &#34;sell (d)&#34; rating on shares of PetMed Express in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, PetMed Express has a consensus rating of &#34;Sell&#34; and a consensus price target of $3.20.</p>
<div class="lb-trans"><p>PETS 已成為幾份分析師報告的主題。華爾街 Zen 在 10 月 18 日的研究報告中將 PetMed Express 的評級從 “持有” 下調至 “賣出”。Zacks Research 在 9 月 29 日的研究報告中將 PetMed Express 的評級從 “強烈賣出” 上調至 “持有”。最後，Weiss Ratings 在 10 月 8 日的研究報告中重申了對 PetMed Express 的 “賣出（d）” 評級。一位投資分析師對該股票給予了 “持有” 評級，另外兩位分析師則給予了 “賣出” 評級。根據 MarketBeat.com 的數據，PetMed Express 的共識評級為 “賣出”，共識目標價為$3.20。</p>
</div><ul>
<li>Here’s The One Pet Stock That’s Not in the Doghouse</li>
</ul>
<div class="lb-trans"><ul>
<li>這裏有一隻不在困境中的寵物股票</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Analysis on PetMed Express</strong></p>
<div class="lb-trans"><p><strong>查看我們對 PetMed Express 的最新股票分析</strong></p>
</div><h2>Institutional Trading of PetMed Express</h2>
<div class="lb-trans"><h2>PetMed Express 的機構交易</h2>
</div><p>Several hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP lifted its position in PetMed Express by 5.4% during the third quarter. Dimensional Fund Advisors LP now owns 481,517 shares of the company's stock valued at $1,209,000 after purchasing an additional 24,624 shares during the last quarter. Man Group plc lifted its holdings in shares of PetMed Express by 7.1% during the 3rd quarter. Man Group plc now owns 151,039 shares of the company's stock worth $379,000 after acquiring an additional 9,989 shares during the last quarter. Bridgeway Capital Management LLC grew its position in PetMed Express by 164.3% in the third quarter. Bridgeway Capital Management LLC now owns 107,816 shares of the company's stock worth $271,000 after acquiring an additional 67,016 shares in the last quarter. CIBC Bancorp USA Inc. bought a new position in PetMed Express in the third quarter valued at $153,000. Finally, Goldman Sachs Group Inc. raised its position in PetMed Express by 59.3% during the first quarter. Goldman Sachs Group Inc. now owns 33,209 shares of the company's stock valued at $139,000 after purchasing an additional 12,360 shares in the last quarter. Institutional investors own 73.33% of the company's stock.</p>
<div class="lb-trans"><p>幾家對沖基金最近增加或減少了對該股票的持倉。Dimensional Fund Advisors LP 在第三季度將其在 PetMed Express 的持倉提高了 5.4%。Dimensional Fund Advisors LP 目前擁有 481,517 股該公司股票，價值$1,209,000，此前在上個季度購買了 24,624 股。Man Group plc 在第三季度將其在 PetMed Express 的持倉提高了 7.1%。Man Group plc 目前擁有 151,039 股該公司股票，價值$379,000，此前在上個季度增加了 9,989 股。Bridgeway Capital Management LLC 在第三季度將其在 PetMed Express 的持倉增加了 164.3%。Bridgeway Capital Management LLC 目前擁有 107,816 股該公司股票，價值$271,000，此前在上個季度增加了 67,016 股。CIBC Bancorp USA Inc.在第三季度購買了 PetMed Express 的新頭寸，價值$153,000。最後，Goldman Sachs Group Inc.在第一季度將其在 PetMed Express 的持倉提高了 59.3%。Goldman Sachs Group Inc.目前擁有 33,209 股該公司股票，價值$139,000，此前在上個季度購買了 12,360 股。機構投資者持有該公司 73.33% 的股票。</p>
</div><h2>PetMed Express Company Profile</h2>
<div class="lb-trans"><h2>PetMed Express 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><ul>
<li>One of these 5 Pet Care Stocks Can Be the Next Short Squeeze</li>
</ul>
<div class="lb-trans"><ul>
<li>這 5 只寵物護理股票中的一隻可能成為下一個空頭擠壓</li>
</ul>
</div><p>PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.</p>
<div class="lb-trans"><p>PetMed Express, Inc.以 1-800-PetMeds 品牌名義運營，作為一家在線和目錄式寵物藥房及零售供應商。該公司直接向消費者分發處方和非處方藥物、營養補充劑、跳蚤和蜱蟲控制產品以及一系列寵物健康用品。通過其位於佛羅里達州德爾雷海灘的持牌獸醫藥房，PetMed Express 為狗、貓和其他伴侶動物處理訂單，提供品牌和仿製產品以及自有品牌配方。</p>
</div><p>Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.</p>
<div class="lb-trans"><p>PetMed Express 於 1996 年由 Marc Puleo 創立，基於為尋求可靠獸醫藥物的寵物主人提供便利和節省成本的理念建立了其業務。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than PetMed Express</li>
<li>Utilities Stocks Explained – How and Why to Invest in Utilities</li>
<li>Nike Beats on Earnings But Struggles in China and Faces Tariffs</li>
<li>Are Penny Stocks a Good Fit for Your Portfolio?</li>
<li>Is the AI Boom a Bubble? These 2 Dividend Stocks Say No</li>
<li>How Investors Can Identify and Successfully Trade Gap-Down Stocks</li>
<li>4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 PetMed Express</li>
<li>公用事業股票解析 – 如何以及為何投資公用事業</li>
<li>Nike 在收益上超預期，但在中國面臨困難並遭遇關税</li>
<li>便士股票適合你的投資組合嗎？</li>
<li>人工智能熱潮是泡沫嗎？這兩隻分紅股票説不是</li>
<li>投資者如何識別併成功交易缺口下跌股票</li>
<li>2026 年四隻高潛力 ETF：小型股、太空股票等</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEVUUw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=PETS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in PetMed Express Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 PetMed Express 嗎？</h2>
</div><p>Before you consider PetMed Express, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 PetMed Express 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PetMed Express wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 PetMed Express 並不在名單上。</p>
</div><p>While PetMed Express currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 PetMed Express 目前在分析師中獲得 “賣出” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

PetMed Express（NASDAQ:PETS）發佈了財報，每股收益比預期低 0.45 美元